Chen, B.; Xu, K.; Zhang, Y.; Xu, P.; Li, C.; Liu, J.; Xu, Y.
RETRACTED: Chen et al. LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway. Cancers 2023, 15, 1902. Cancers 2026, 18, 1229.
https://doi.org/10.3390/cancers18081229
AMA Style
Chen B, Xu K, Zhang Y, Xu P, Li C, Liu J, Xu Y.
RETRACTED: Chen et al. LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway. Cancers 2023, 15, 1902. Cancers. 2026; 18(8):1229.
https://doi.org/10.3390/cancers18081229
Chicago/Turabian Style
Chen, Binshen, Kai Xu, Yiming Zhang, Peng Xu, Chaoming Li, Jun Liu, and Yawen Xu.
2026. "RETRACTED: Chen et al. LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway. Cancers 2023, 15, 1902" Cancers 18, no. 8: 1229.
https://doi.org/10.3390/cancers18081229
APA Style
Chen, B., Xu, K., Zhang, Y., Xu, P., Li, C., Liu, J., & Xu, Y.
(2026). RETRACTED: Chen et al. LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway. Cancers 2023, 15, 1902. Cancers, 18(8), 1229.
https://doi.org/10.3390/cancers18081229
